Back to Search
Start Over
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab.
- Source :
-
Leukemia [Leukemia] 2018 Aug; Vol. 32 (8), pp. 1869-1873. Date of Electronic Publication: 2018 Mar 20. - Publication Year :
- 2018
- Subjects :
- Aged
Aged, 80 and over
Bendamustine Hydrochloride administration & dosage
Cohort Studies
Female
Follow-Up Studies
Humans
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell metabolism
Male
Middle Aged
Neoplasm Recurrence, Local drug therapy
Neoplasm Recurrence, Local metabolism
Prognosis
Rituximab administration & dosage
Survival Rate
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Biomarkers, Tumor analysis
Leukemia, Lymphocytic, Chronic, B-Cell pathology
Neoplasm Recurrence, Local pathology
Severity of Illness Index
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 32
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 29588545
- Full Text :
- https://doi.org/10.1038/s41375-018-0100-6